UB Paderborn / Katalog / Suche / in CDI

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer

Annals of oncology, 2009-09, Vol.20 (9), p.1529-1534

2009

Volltextzugriff (PDF)

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

Annals of oncology, 2005-08, Vol.16 (8), p.1305-1310

2005

Volltextzugriff (PDF)

Pentoxifylline to Treat Radiation Proctitis: A Small and Inconclusive Randomised Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-05, Vol.20 (4), p.288-292

2008

Volltextzugriff (PDF)

Predictive poor prognostic factors in colonic carcinoma

Surgical oncology, 2006-08, Vol.15 (2), p.71-78

2006

Volltextzugriff (PDF)

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

Annals of oncology, 2003-01, Vol.14 (1), p.91-96

2003

Volltextzugriff (PDF)

Corrigendum to: Pentoxifylline to Treat Radiation Proctitis: A Small and Inconclusive Randomised Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-06, Vol.20 (5), p.386-386

2008

Volltextzugriff (PDF)

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

Annals of oncology, 2005-04, Vol.16 (4), p.549-557

2005

Volltextzugriff (PDF)

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

European journal of cancer (1990), 1998-03, Vol.34 (4), p.503-509

1998

Volltextzugriff (PDF)

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases

Gut, 2003-04, Vol.52 (4), p.568-573

2003

Volltextzugriff (PDF)

The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials

Annals of oncology, 2009-05, Vol.20 (5), p.885-891

2009

Volltextzugriff (PDF)

Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma

Annals of oncology, 2004-01, Vol.15 (1), p.64-69

2004

Volltextzugriff (PDF)

4004 ORAL Avoiding overtreatment of prostate cancer: optimising patient selection for active surveillance

European journal of cancer supplements, 2007, Vol.5 (4), p.280-280

2007

Volltextzugriff (PDF)

Failure of dietetic referral in patients with gastrointestinal cancer and weight loss

European journal of cancer (1990), 2006-10, Vol.42 (15), p.2504-2509

2006

Volltextzugriff (PDF)

Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital

BJU international, 2003-11, Vol.92 (7), p.685-689

2003

Volltextzugriff (PDF)

The Significance of Raised C-reactive Protein in Patients with Late Radiation-induced Bowel Symptoms

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006-06, Vol.18 (5), p.425-425

2006

Volltextzugriff (PDF)

Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone

Radiotherapy and oncology, 2001-04, Vol.59 (1), p.5-11

2001

Volltextzugriff (PDF)

Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in Assessing Prognosis and Predicting First-Line Treatment Efficacy in Follicular Lymphoma Patients

Acta haematologica, 2009-01, Vol.122 (4), p.193-199

2009

Volltextzugriff (PDF)

Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injury

European journal of cancer care, 2007-07, Vol.16 (4), p.346-350

2007

Volltextzugriff (PDF)

A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary

European journal of cancer (1990), 2003-05, Vol.39 (8), p.1121-1128

2003

Volltextzugriff (PDF)

Assessing the Incidence of Bowel Incontinence in Patients with Urological Cancers Who Have and Have Not Received Pelvic Radiotherapy using the Vaizey and RTOG: Interim Results

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006-06, Vol.18 (5), p.423-423

2006

Volltextzugriff (PDF)

Recovery of Serum Testosterone, LH and FSH Levels Following Neoadjuvant Hormone Cytoreduction and Radical Radiotherapy in Localized Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2001-08, Vol.13 (4), p.291-295

2001

Volltextzugriff (PDF)

Effect of neoadjuvant (Short Course) LHRH analogue treatment with radical radiotherapy on long term hormonal status of patients with localised prostate cancer

European journal of cancer (1990), 1999-09, Vol.35, p.S341-S341

1999

Volltextzugriff (PDF)

RE: TIME TO NORMALIZATION OF SERUM TESTOSTERONE AFTER 3-MONTH LUTEINIZING HORMONE-RELEASING HORMONE AGONIST ADMINISTERED IN THE NEOADJUVANT SETTING: IMPLICATIONS FOR DOSING SCHEDULE AND NEOADJUVANT STUDY CONSIDERATION

The Journal of urology, 1999, Vol.162 (1), p.170-170

1999

Volltextzugriff (PDF)

In regard to padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439–443

International journal of radiation oncology, biology, physics, 2002-11, Vol.54 (3), p.981-981

2002

Volltextzugriff (PDF)

MR Evaluation of Normal Retroperitoneal and Pelvic Lymph Nodes

Clinical radiology, 2002-03, Vol.57 (3), p.203-204

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

Pentoxifylline to Treat Radiation Proctitis: A Small and Inconclusive Randomised Trial

Predictive poor prognostic factors in colonic carcinoma

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

Corrigendum to: Pentoxifylline to Treat Radiation Proctitis: A Small and Inconclusive Randomised Trial

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases

The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials

Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma

4004 ORAL Avoiding overtreatment of prostate cancer: optimising patient selection for active surveillance

Failure of dietetic referral in patients with gastrointestinal cancer and weight loss

Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital

The Significance of Raised C-reactive Protein in Patients with Late Radiation-induced Bowel Symptoms

Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone

Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in Assessing Prognosis and Predicting First-Line Treatment Efficacy in Follicular Lymphoma Patients

Elevated C-reactive protein levels are not a feature of uncomplicated radiation-induced bowel injury

A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary

Assessing the Incidence of Bowel Incontinence in Patients with Urological Cancers Who Have and Have Not Received Pelvic Radiotherapy using the Vaizey and RTOG: Interim Results

Recovery of Serum Testosterone, LH and FSH Levels Following Neoadjuvant Hormone Cytoreduction and Radical Radiotherapy in Localized Prostate Cancer

Effect of neoadjuvant (Short Course) LHRH analogue treatment with radical radiotherapy on long term hormonal status of patients with localised prostate cancer

RE: TIME TO NORMALIZATION OF SERUM TESTOSTERONE AFTER 3-MONTH LUTEINIZING HORMONE-RELEASING HORMONE AGONIST ADMINISTERED IN THE NEOADJUVANT SETTING: IMPLICATIONS FOR DOSING SCHEDULE AND NEOADJUVANT STUDY CONSIDERATION

In regard to padula et al., normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. IJROBP 2002;52: 439–443

MR Evaluation of Normal Retroperitoneal and Pelvic Lymph Nodes

Suchergebnisse filtern